Cosmetic Regulation Update's Link With OTC Drug User Fees Clear At Hearing

Members of the House Health Subcommittee suggest their support for potential OTC monograph reform legislation depends on including provisions that would add substantial details to FDA's oversight of cosmetics manufacturers and a related user fee program.

Capitol House

Updating FDA regulations for cosmetics manufacturing this year could be linked to legislation on establishing a user fee program to pay for improving its OTC drug monograph program, according to members of the House committee with oversight of the agency.

At a Sept. 11 hearing, members of the Energy and Commerce Committee's Health Subcommittee suggested that their support for potential OTC monograph reform legislation depends on including provisions that would...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Legislation

More from Policy & Regulation